BRIEF published on 10/27/2025 at 07:35, 1 month 9 days ago Evotec Advances in Neuroscience Partnership with Bristol Myers Squibb Partnership Neuroscience Evotec Bristol Myers Squibb Neurodegenerative
PRESS RELEASE published on 10/27/2025 at 07:30, 1 month 9 days ago Evotec announces progress in preclinical neuroscience partnership with Bristol Myers Squibb Evotec SE announces US$ 25 m payment from Bristol Myers Squibb for progress in preclinical neuroscience partnership, advancing research on neurodegenerative diseases Partnership Evotec SE Neurodegenerative Diseases Bristol Myers Squibb Research Progress
BRIEF published on 08/13/2025 at 07:05, 3 months 23 days ago Evotec SE Reports H1 2025 Results Highlighting Strategic Progress Financial Performance Evotec SE Strategic Growth Biologics Development H1 2025 Results
PRESS RELEASE published on 08/13/2025 at 07:00, 3 months 23 days ago Evotec SE reports H1 2025 results: Strong progress on strategy execution Evotec SE reports strong progress on strategy execution with H1 2025 results, showcasing sustainable profitable growth and key collaborations with BMS and Sandoz Evotec SE Growth Collaborations Strategy Execution H1 2025 Results
BRIEF published on 08/06/2025 at 09:57, 3 months 29 days ago Evotec SE to Release First Half-Year Results 2025 Conference Call Drug Discovery Life Sciences Evotec SE Half-year Results
PRESS RELEASE published on 08/06/2025 at 09:52, 3 months 29 days ago Evotec SE to announce first half-year results 2025 on 13 August 2025 Evotec SE to announce first half-year results for 2025 on 13 August 2025 with a conference call to discuss performance. Company focuses on drug discovery and development Conference Call Drug Discovery Evotec SE Half-year Results AI-driven Innovation
BRIEF published on 07/30/2025 at 07:21, 4 months 6 days ago Evotec and Sandoz Advance Partnership with Potential Toulouse Site Sale Strategic Partnership Evotec SE Biologics Manufacturing Sandoz AG Asset-Lighter Model
BRIEF published on 07/30/2025 at 07:19, 4 months 6 days ago Evotec SE and Sandoz AG to Potentially Sell Just – Evotec Biologics Toulouse Site Evotec SE Transaction Terms Sandoz AG Biologics Sale Toulouse Site
PRESS RELEASE published on 07/30/2025 at 07:16, 4 months 6 days ago Evotec and Sandoz evolve their strategic partnership and agree on potential sale of Just – Evotec Biologics Toulouse site Evotec and Sandoz agree on potential sale of Just – Evotec Biologics Toulouse site in strategic partnership evolution Strategic Partnership Sale Evotec Sandoz Biologics
PRESS RELEASE published on 07/30/2025 at 07:14, 4 months 6 days ago EQS-Adhoc: Evotec SE and Sandoz AG planning potential sale of Just – Evotec Biologics Toulouse site Evotec SE and Sandoz AG plan potential sale of Just - Evotec Biologics Toulouse site for $300m in cash with additional technology related consideration. Evotec to retain economic upside Evotec SE Sale Just - Evotec Biologics Toulouse Sandoz AG
Published on 12/05/2025 at 02:35, 6 hours 55 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 8 hours 30 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 25 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 30 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:05, 25 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 45 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 15 hours 30 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 15 hours 45 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 15 hours 46 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 2 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
